Adaptive Phage Therapeutics (APT), a Gaithersburg, Md.-based clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, closed a $40.75m Series B funding.
(Article on Page 9) Princess Anne part-time inventor, David White, has invented, a robotic capsule to assist gastrointestinal doctors with endoscopy procedures.
The Maryland Stem Cell Research Commission has also appointed Amritha Jaishankar, Ph.D., the current MSCRF Director – Programs & Strategic Alliances, to succeed Dan Gincel, Ph.D., as Executive Director of the MSCRF, effective May 14, 2021.
Troy LeMaile-Stovall, TEDCO’s CEO, said his organization and its partners wanted to be "more intentional" about creating connection and accessibility across the entrepreneurial ecosystem.
The report also notes the most active investors in the 193 companies analyzed in the report. TEDCO tops the list, having invested 75 deals in these companies, followed by The Abell Foundation at 24.
TEDCO Talks: A new virtual series featuring thought leaders in economic development from across the State of Maryland. TEDCO's CEO & Executive Director, Troy LeMaile-Stovall had the opportunity to interview President David Wilson of Morgan State University (MSU).
In 2012 when TEDCO’s Maryland Innovation Initiative (MII) was created, Maryland ranked 38th in the nation for commercialization. Today, it ranks 8th.
Trial funded in part by a grant from Maryland Technology Development Corporation (TEDCO) and the National Institute on Aging (NIA) of the National Institutes of Health (NIH)
TEDCO was established in 1998 by the Maryland General Assembly to assist with funding and to serve as a resource for burgeoning technology-based businesses.
BondTrue, a medical device design and development company, won a Small Business Innovation Research grant from the federal government. Here's what led to succcess on the company's second application.
